Skip to Main Content

CAMBRIDGE, Mass. — Starting a biotech used to be simpler, conceptually speaking; some scientist with an idea would pitch it to people with money. After a dozen years — and as many lucky breaks — that scientist might have a successful company.

That doesn’t happen as much anymore. Some say that era is over. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!